Serum HBV pgRNA as a clinical marker for cccDNA activity.
about
The Role of cccDNA in HBV Maintenance.Detection of HBV Covalently Closed Circular DNAHepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA VariantsSerum Hepatitis B Virus DNA, RNA, and HBsAg: Which Correlated Better with Intrahepatic Covalently Closed Circular DNA before and after Nucleos(t)ide Analogue Treatment?Host and viral factors associated with serum hepatitis B virus RNA levels among patients in need for treatment.
P2860
Serum HBV pgRNA as a clinical marker for cccDNA activity.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@en
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@nl
type
label
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@en
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@nl
prefLabel
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@en
Serum HBV pgRNA as a clinical marker for cccDNA activity.
@nl
P2093
P1476
Serum HBV pgRNA as a clinical marker for cccDNA activity
@en
P2093
Katja Giersch
Lena Allweiss
Marc Lütgehetmann
Maura Dandri
P304
P356
10.1016/J.JHEP.2016.09.028
P50
P577
2016-11-05T00:00:00Z